U.S. stock market midday update: Akari Therap down 8.79% with no major negative news, increased volatility due to capital speculationPrice Alert·4 hours agoAKTX-2.52%
Pre-market hot trades in US stocks: ServiceNow pre-market down 3.23%, AI replacement concerns ease, executives' sell-off causes volatilityPrice Alert·8 hours agoNOW+2.27%
Weekly Recap | LABU.US -6.76%, Friday erases weekly gainsWeekly Review·2 days ago, 02:11 AMLABU+0.19%
Weekly Recap | iShares Russell 2000 -1.4%, trailing the S&P 500Weekly Review·2 days ago, 02:08 AMIWM-0.62%
Weekly Recap | Viking Therap -5.1%, consensus target above spotWeekly Review·2 days ago, 01:40 AMVKTX+1.93%
Weekly Recap | Vertex Pharma -1.16%, most brokers rate it buyWeekly Review·2 days ago, 01:39 AMVRTX+0.52%
Weekly Recap | Summit Therapeutics +4.33%, Phase III data beats ImfinziWeekly Review·2 days ago, 01:29 AMSMMT-0.80%
Weekly Recap | Sellas Life Sciences -14.55%, consensus target more than double spotWeekly Review·2 days ago, 01:25 AMSLS+0.98%
Weekly Recap | Regeneron Pharma -4.78%, consensus target above spotWeekly Review·2 days ago, 01:22 AMREGN+0.62%
ROCKET PHARMACEUTICALS INC C/WTS 02/09/2026 (TO PUR COM) | 8-K: FY2026 Q1 Revenue: USD 0Earnings Watch·May 7 at 04:16 PMRCKTW-42.86%
ROCKET PHARMACEUTICALS INC C/WTS 02/09/2026 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0Earnings Watch·Nov 6, 2025 at 03:25 PMRCKTW-42.86%
ROCKET PHARMACEUTICALS INC C/WTS 02/09/2026 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -0.62Earnings Watch·Aug 7, 2025 at 03:10 PMRCKTW-42.86%
ROCKET PHARMACEUTICALS INC C/WTS 02/09/2026 (TO PUR COM) | 8-K: FY2025 Q2 EPS: USD -0.62Earnings Watch·Aug 7, 2025 at 03:04 PMRCKTW-42.86%
ROCKET PHARMACEUTICALS INC C/WTS 02/09/2026 (TO PUR COM) | 8-K: FY2025 Q1 EPS: USD -0.56Earnings Watch·May 8, 2025 at 03:14 PMRCKTW-42.86%
ROCKET PHARMACEUTICALS INC C/WTS 02/09/2026 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -0.56Earnings Watch·May 8, 2025 at 03:04 PMRCKTW-42.86%
